Single award · contract
Takeda Zika Virus
Award ID: HHSO100201600015C
A single federal award, with both ends of the trail linked.
$100.4M
Total award value
Award HHSO100201600015C is a contract from the Department of Health and Human Services, $100.4M obligated, FY2016 to FY2024, for Takeda Zika Virus. It is classified as NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) and PSC AN13 (Health R&D Services; Health Care Services; Experimental Development). Source
Description
Igf::ot::igf Takeda Zika Virus
Award details
Award typeContract
PIIDHHSO100201600015C
Action date2016
Period97 mo
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performance—
CategoryNAICS 325413PSC AN13
Competed?Not recordedSource
Total (exact)$100,440,882
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.